XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Playback speed
10 seconds
Ibrutinib-Obinutuzumab For R/R Nodal MZL: A Case Study
10 views
February 16, 2024
Comments 0
Login to view comments.
Click here to Login
Lymphoma